About Pandorum Technologies
Pandorum Technologies is a company founded in 2011. The company has 27 employees. Pandorum Technologies offers products and services including Bioengineered Cornea and Mini Liver.
- Employees 27
- SectorsHealthcare
- Phone•••• ••••
- Social LinkedIn Facebook
- Legal Name Pandorum Technologies Pvt. Ltd
- Date of Incorporation 16 May, 2011
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹3.53 Cr
FY 2025 · +322% YoY
- Net Loss-₹29.07 Cr
FY 2025 · -825% margin
- EBITDA-₹27.71 Cr
FY 2025 · -786% margin
- Employee Count27
Associated legal entities of Pandorum Technologies
Pandorum Technologies operates through Pandorum Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pandorum Technologies Private Limited CIN U72200KA2011PTC058650 | Active | 16 May 2011 | Bengaluru, Karnataka | ₹3.5 Cr | 27 | 6 | View details |
Products & Services of Pandorum Technologies
Pandorum Technologies offers a comprehensive portfolio of products and services, including Bioengineered Cornea and Mini Liver.
A bioengineered product is provided for treating various corneal disorders, with an emphasis on patient safety and vision restoration.
An in vitro liver organoid is offered as a model for drug discovery, facilitating studies that mimic in vivo microenvironments.
Board of directors of Pandorum Technologies Private Limited (Pandorum Technologies)
Pandorum Technologies Private Limited is the primary company behind Pandorum Technologies. The board of Pandorum Technologies Private Limited currently have 6 directors; the longest-serving is Arun Chandru Raja, appointed in 2011. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Arun Chandru Raja DIN 03474748 | Director | 16 May 2011 | 15 yrs 4 mo | Pandorum Technologies Private Limited |
| Tuhin Bhowmick DIN 03474756 | Director | 16 May 2011 | 15 yrs 4 mo | Pandorum Technologies Private Limited |
| Sonal Asthana DIN 07073986 | Director | 14 Nov 2016 | 9 yrs 10 mo | Pandorum Technologies Private Limited |
| Manish Kumar Belmannu DIN 00324519 | Nominee Director | 18 Jul 2018 | 8 yrs 2 mo | Pandorum Technologies Private Limited |
| Sailesh Tulshan DIN 07309300 | Director | 10 Aug 2018 | 8 yrs 2 mo | Pandorum Technologies Private Limited |
| Sudipta Gautam DIN 02896765 | Nominee Director | 18 Dec 2019 | 6 yrs 9 mo | Pandorum Technologies Private Limited |
People of Pandorum Technologies
23 people are tracked at Pandorum Technologies (4 in leadership, 19 in team); the tracked headcount is 27.
| Name | Role | Group |
|---|---|---|
| CEO & Director | Leadership | |
| CTO & Director | Leadership | |
Phani Kiran Karra | Director of Finance | Leadership |
Nadig Satish | Chief Medical Advisor | Leadership |
Bharti Sangwan | Assistant Research Scientist, Optometry | Team |
Rita Das Mahapatra | Research Scientist, Biomaterials | Team |
Anil Kumar | Senior Research Scientist | Team |
Anbalagan Jaganathan | Senior Research Scientist | Team |
Mujib Ullah | Senior Research Scientist | Team |
Alka Bhat | Research Scientist | Team |
Mehak Sapra | Research Scientist | Team |
Nisha P R | Research Scientist | Team |
Parinita Agrawal | Senior Research Scientist | Team |
Rakesh Dey | Consultant Bioinformatics | Team |
Suvro Kanti Chowdhury | Research Scientist | Team |
Shivani Mahapatra | Executive Administrator | Team |
Ravi Chandra | Senior Manager, Finance & Accounts | Team |
Monika Chouhan | Clinical Coordinator | Team |
Sridhar R | Associate Manager Accounts & Admin | Team |
Sarabjit Kumar | Lab Assistant | Team |
3 more people are available in the full profile.
Complete people profiles for Pandorum Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Pandorum Technologies
Figures of Pandorum Technologies Private Limited, the primary company behind Pandorum Technologies, for FY 2025. Revenue was ₹3.53 Cr (+322% year on year). Net loss was -₹29.07 Cr (-825% margin). EBITDA was -₹27.71 Cr (-786% margin). Revenue has grown at a compounded annual rate of +76% over three years and +54% over five years.
- ₹3.53 CrRevenue · FY 2025 · +322% YoY
- -₹29.07 CrNet loss · -825% margin
- -₹27.71 CrEBITDA · -786% margin
- ₹4.68 CrPaid-up capital
- 27Employees (provident fund records)
- +76%Revenue CAGR, 3 years
- +54%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pandorum Technologies Private Limited are on its company page.
Detailed financial statements for Pandorum Technologies
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Latest news on Pandorum Technologies
Complete news archive for Pandorum Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Pandorum Technologies
10 companies that operate in the same segment as Pandorum Technologies (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pandorum Technologies
Pandorum Technologies was founded in 2011.
Pandorum Technologies has 27 employees.
The primary company behind Pandorum Technologies, Pandorum Technologies Private Limited, reported revenue of ₹3.53 Cr for FY 2025, up 322% year on year.
Pandorum Technologies is engaged in tissue engineering and regenerative medicine, where functional human tissues such as bioengineered corneas and liver organoids are developed using proprietary platforms for medical research and therapeutic applications. Cell-free therapies for tissue repair and regeneration are also pursued, with a focus on translational science to benefit human health. Offices are operated in Bangalore, India, and San Carlos, USA, alongside partnerships that support innovations in drug discovery and lung treatments. Commitments to safety and efficacy are evident in these efforts.
Pandorum Technologies offers Bioengineered Cornea and Mini Liver.
Pandorum Technologies operates through Pandorum Technologies Private Limited.
The legal entities of Pandorum Technologies currently have 6 directors, including Manish Kumar Belmannu, Arun Chandru Raja, Tuhin Bhowmick and others.